Company: CERO
Filing Date: 2025-10-23
Form Type: 424B3
Source: 0001213900-25-101650
Chunk: 15

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-10-23
Form: 424B3
Chunk 15
---
1 of the Company’s Current Report on Form 8-K (File No. 001-40877) filed on October 14, 2025). |
|:------------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 104         |     | Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                                                                                                             |

| * | Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. |

| † | Certain portions of this document that constitute confidential information have been redacted pursuant to Item 601(b)(10) of Regulation S-K. |

<div align='center'>1

SIGNATURE</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

| Dated: October 16, 2025 | CERO THERAPEUTICS HOLDINGS, INC. |                         |
|:------------------------|:---------------------------------|:------------------------|
|                         | By:                              | /s/ Chris Ehrlich       |
|                         | Name:                            | Chris Ehrlich           |
|                         | Title:                           | Chief Executive Officer |

<div align='center'>2</div>